Paul Landais
Overview
Explore the profile of Paul Landais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
2943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amselem S, Gueguen S, Weinbach J, Clement A, Landais P
Orphanet J Rare Dis
. 2021 Oct;
16(1):454.
PMID: 34715889
Background: Rare diseases (RDs) affect nearly 3 million people in France and at least 26-30 million people in Europe. These diseases, which represent a major medical concern, are mainly of...
2.
Bonnet E, Daures J, Landais P
Sci Rep
. 2021 Sep;
11(1):19104.
PMID: 34580360
In France, more than 10 million women at "average" risk of breast cancer (BC), are included in the organized BC screening. Existing predictive models of BC risk are not adapted...
3.
Pinaire J, Aze J, Bringay S, Poncelet P, Genolini C, Landais P
Health Informatics J
. 2021 Sep;
27(3):14604582211033020.
PMID: 34474603
Acute coronary syndrome (ACS) in women is a growing public health issue and a death leading cause. We explored whether the hospital healthcare trajectory was characterizable using a longitudinal clustering...
4.
Messiaen C, Racine C, Khatim A, Soussand L, Odent S, Lacombe D, et al.
Orphanet J Rare Dis
. 2021 Aug;
16(1):345.
PMID: 34348744
Background: In France, the Ministry of Health has implemented a comprehensive program for rare diseases (RD) that includes an epidemiological program as well as the establishment of expert centers for...
5.
Pinaire J, Chabert E, Aze J, Bringay S, Landais P
J Healthc Eng
. 2021 Jun;
2021:5531807.
PMID: 34122784
Prediction of a medical outcome based on a trajectory of care has generated a lot of interest in medical research. In sequence prediction modeling, models based on machine learning (ML)...
6.
Pinaire J, Chabert E, Aze J, Bringay S, Poncelet P, Landais P
Stud Health Technol Inform
. 2021 May;
281:293-297.
PMID: 34042752
Study of trajectory of care is attractive for predicting medical outcome. Models based on machine learning (ML) techniques have proven their efficiency for sequence prediction modeling compared to other models....
7.
Garrel R, Poissonnet G, Moya Plana A, Fakhry N, Dolivet G, Lallemant B, et al.
J Clin Oncol
. 2020 Oct;
38(34):4010-4018.
PMID: 33052754
Purpose: Sentinel node (SN) biopsy is accurate in operable oral and oropharyngeal cT1-T2N0 cancer (OC), but, to our knowledge, the oncologic equivalence of SN biopsy and neck lymph node dissection...
8.
Winter A, Landais P, Azoulay D, Disabato M, Compagnon P, Antoine C, et al.
JHEP Rep
. 2020 Jul;
2(4):100118.
PMID: 32695966
Background & Aims: In France, liver grafts that have been refused at least 5 times can be "rescued" and allocated to a centre which chooses a recipient from its own...
9.
Nguyen T, Collins G, Landais P, Le Manach Y
J Clin Epidemiol
. 2020 May;
125:47-56.
PMID: 32464321
Objective: Causal treatment effects are estimated at the population level in randomized controlled trials, while clinical decision is often to be made at the individual level in practice. We aim...
10.
Winter A, Feray C, Antoine C, Azoulay D, Daures J, Landais P
Sci Rep
. 2020 Mar;
10(1):4111.
PMID: 32139780
Persistent shortage and heterogeneous quality of liver grafts encourages the optimization of donor-recipient matching in liver transplantation (LT). We explored whether or not there was a survival benefit (SB) of...